Balentine LLC Illumina, Inc. Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$127.73 - $147.2 $79,064 - $91,116	619 Added 26.51%	2,954 $405,000
Q4 2023 Feb 09, 2024	BUY	$92.79 - $142.53 $216,664 - $332,807	2,335 New	2,335 $325,000
Q1 2023 May 11, 2023	SELL	$193.75 - $232.55 $111,406 - $133,716	-575 Reduced 23.94%	1,827 $424,000
Q4 2022 Jan 31, 2023	SELL	$187.24 - $242.74 $25,839 - $33,498	-138 Reduced 5.43%	2,402 $485,000
Q3 2022 Oct 26, 2022	BUY	$177.23 - $227.44 $450,164 - $577,697	2,540 New	2,540 $485,000
Q1 2022 Oct 26, 2022	BUY	$303.87 - $423.8 $202,681 - $282,674	667 New	667 $233,000
Q4 2021 Oct 26, 2022	BUY	$347.28 - $421.83 $182,322 - $221,460	525 New	525 $200,000
Q4 2021 Feb 02, 2022	SELL	$347.28 - $421.83 $177,112 - $215,133	-510 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $405 - $524	1 Added 0.2%	510 $207,000
Q2 2021 Aug 16, 2021	BUY	$372.84 - $481.5 $189,775 - $245,083	509 New	509 $241,000
Q3 2020 Nov 02, 2020	SELL	$268.51 - $400.74 $132,912 - $198,366	-495 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $12,566 - $18,277	-49 Reduced 9.01%	495 $183,000
Q1 2020 May 18, 2020	BUY	$209.2 - $335.53 $74,893 - $120,119	358 Added 192.47%	544 $149,000
Q4 2019 Sep 02, 2020	BUY	$288.29 - $335.49 $50,739 - $59,046	176 Added 1760.0%	186 $62,000
Q3 2019 Nov 15, 2019	SELL	$266.84 - $378.23 $2,134 - $3,025	-8 Reduced 44.44%	10 $3,000
Q2 2019 Aug 14, 2019	BUY	$300.59 - $368.15 $5,410 - $6,626	18 New	18 $7,000
Q1 2018 May 16, 2018	SELL	$209.54 - $253.91 $12,781 - $15,488	-61 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$172.3 - $213.93 $10,510 - $13,049	61	61 $12,000

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account